NVE Corp: Form 10-Q for the period ended Dec 31, 2020
Filed with the SEC on Jan 20, 2021 and accepted by EDGAR at Jan 20, 2021, 21:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-10-01 to 2020-12-31 | $6.5m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2020-04-01 to 2020-12-31 | $15.5m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2020-10-01 to 2020-12-31 | $1.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2020-04-01 to 2020-12-31 | $2.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2020-10-01 to 2020-12-31 | $5.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-04-01 to 2020-12-31 | $12.7m | us-gaap:GrossProfit |
| Research and development | 3 months2020-10-01 to 2020-12-31 | $702.2k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-04-01 to 2020-12-31 | $2.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-10-01 to 2020-12-31 | $311.4k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-04-01 to 2020-12-31 | $1.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-10-01 to 2020-12-31 | $4.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-04-01 to 2020-12-31 | $9.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-10-01 to 2020-12-31 | $884.5k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-04-01 to 2020-12-31 | $1.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-10-01 to 2020-12-31 | $3.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-04-01 to 2020-12-31 | $8.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-10-01 to 2020-12-31 | $0.81 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-04-01 to 2020-12-31 | $1.77 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-10-01 to 2020-12-31 | $0.81 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-04-01 to 2020-12-31 | $1.77 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-10-01 to 2020-12-31 | 4,833,261 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-04-01 to 2020-12-31 | 4,834,411 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-04-01 to 2020-12-31 | $8.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-04-01 to 2020-12-31 | $13.6k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2020-04-01 to 2020-12-31 | $14.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2020-04-01 to 2020-12-31 | $91.4k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-12-31 | $14.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $32.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $74.4m | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $748.9k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $1.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-12-31 | $73.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000724910-21-000004. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.